(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
Our medical professionals often recommend starting by slowly including more exercise in your normal routine
Tips for Vibrant Hair, Skin, and Joint Health Collagen is the most abundant protein in the body, found in the skin, muscles, bones, tendons, and ligaments
The article puts semaglutide patent expiry between 2027 and 2033 depending on formulation and jurisdiction, and says tirzepatide runs later, with some patents extending to 2038 or 2040